This is my point, I think the uptake for the wheezo will be like Australia whether in Europe or US, initially I thought the uptake will be low due to the limited market but now I'm starting to question if it's the technology as all it does is detect wheeze so the uptake will be even lower than I expected which does explain the even more disappointing quarterly than even I thought. Those relying on CPT from oversea government....
Ann: Proposed issue of Securities - RSH, page-167
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 800000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 508500 | 3 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable